 It harnesses the power of the body 's immune system and targets it at tumours .
Early experiments have demonstrated that the new method could revolutionise cancer care .
The team found that early trials ` profoundly retarded ' tumour growth in mice .
Survival rates were boosted by more than 50 per cent .